Academic Journal
View in EDS

15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study

Bibliographic Details
Title: 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study
Authors: Max Augustin, Melanie Stecher, Hauke Wüstenberg, Veronica Di Cristanziano, Ute Sandaradura de Silva, Lea Katharina Picard, Elisabeth Pracht, Dominic Rauschning, Henning Gruell, Florian Klein, Christoph Wenisch, Michael Hallek, Philipp Schommers, Clara Lehmann
Source: Frontiers in Immunology, Vol 14 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: post-COVID syndrome, PCS, long COVID, therapeutic vaccination, symptom clusters, outcome, Immunologic diseases. Allergy, RC581-607
More Details: BackgroundWhile the short-term symptoms of post-COVID syndromes (PCS) are well-known, the long-term clinical characteristics, risk factors and outcomes of PCS remain unclear. Moreover, there is ongoing discussion about the effectiveness of post-infection vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) to aid in PCS recovery.MethodsIn this longitudinal and observational case-control study we aimed at identifying long-term PCS courses and evaluating the effects of post-infection vaccinations on PCS recovery. Individuals with initial mild COVID-19 were followed for a period of 15 months after primary infection. We assessed PCS outcomes, distinct symptom clusters (SC), and SARS-CoV-2 immunoglobulin G (IgG) levels in patients who received SARS-CoV-2 vaccination, as well as those who did not. To identify potential associating factors with PCS, we used binomial regression models and reported the results as odds ratios (OR) with 95% confidence intervals (95%CI).ResultsOut of 958 patients, follow-up data at 15 month after infection was obtained for 222 (23.2%) outpatients. Of those individuals, 36.5% (81/222) and 31.1% (69/222) were identified to have PCS at month 10 and 15, respectively. Fatigue and dyspnea (SC2) rather than anosmia and ageusia (SC1) constituted PCS at month 15. SARS-CoV-2 IgG levels were equally distributed over time among age groups, sex, and absence/presence of PCS. Of the 222 patients, 77.0% (171/222) were vaccinated between 10- and 15-months post-infection, but vaccination did not affect PCS recovery at month 15. 26.3% of unvaccinated and 25.8% of vaccinated outpatients improved from PCS (p= .9646). Baseline headache (SC4) and diarrhoea (SC5) were risk factors for PCS at months 10 and 15 (SC4: OR 1.85 (95%CI 1.04-3.26), p=.0390; SC5: OR 3.27(95%CI 1.54-6.64), p=.0009).ConclusionBased on the specific symptoms of PCS our findings show a shift in the pattern of recovery. We found no effect of SARS-CoV-2 vaccination on PCS recovery and recommend further studies to identify predicting biomarkers and targeted PCS therapeutics.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1226622/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2023.1226622
Access URL: https://doaj.org/article/cd68ffa85084495d8def15fe468e058c
Accession Number: edsdoj.68ffa85084495d8def15fe468e058c
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16643224&ISBN=&volume=14&issue=&date=20230901&spage=&pages=&title=Frontiers in Immunology&atitle=15-month%20post-COVID%20syndrome%20in%20outpatients%3A%20Attributes%2C%20risk%20factors%2C%20outcomes%2C%20and%20vaccination%20status%20-%20longitudinal%2C%20observational%2C%20case-control%20study&aulast=Max%20Augustin&id=DOI:10.3389/fimmu.2023.1226622
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/cd68ffa85084495d8def15fe468e058c
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.68ffa85084495d8def15fe468e058c
RelevancyScore: 975
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 975.256042480469
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Max+Augustin%22">Max Augustin</searchLink><br /><searchLink fieldCode="AR" term="%22Melanie+Stecher%22">Melanie Stecher</searchLink><br /><searchLink fieldCode="AR" term="%22Hauke+Wüstenberg%22">Hauke Wüstenberg</searchLink><br /><searchLink fieldCode="AR" term="%22Veronica+Di+Cristanziano%22">Veronica Di Cristanziano</searchLink><br /><searchLink fieldCode="AR" term="%22Ute+Sandaradura+de+Silva%22">Ute Sandaradura de Silva</searchLink><br /><searchLink fieldCode="AR" term="%22Lea+Katharina+Picard%22">Lea Katharina Picard</searchLink><br /><searchLink fieldCode="AR" term="%22Elisabeth+Pracht%22">Elisabeth Pracht</searchLink><br /><searchLink fieldCode="AR" term="%22Dominic+Rauschning%22">Dominic Rauschning</searchLink><br /><searchLink fieldCode="AR" term="%22Henning+Gruell%22">Henning Gruell</searchLink><br /><searchLink fieldCode="AR" term="%22Florian+Klein%22">Florian Klein</searchLink><br /><searchLink fieldCode="AR" term="%22Christoph+Wenisch%22">Christoph Wenisch</searchLink><br /><searchLink fieldCode="AR" term="%22Michael+Hallek%22">Michael Hallek</searchLink><br /><searchLink fieldCode="AR" term="%22Philipp+Schommers%22">Philipp Schommers</searchLink><br /><searchLink fieldCode="AR" term="%22Clara+Lehmann%22">Clara Lehmann</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Frontiers in Immunology, Vol 14 (2023)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Frontiers Media S.A., 2023.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2023
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Immunologic diseases. Allergy
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22post-COVID+syndrome%22">post-COVID syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22PCS%22">PCS</searchLink><br /><searchLink fieldCode="DE" term="%22long+COVID%22">long COVID</searchLink><br /><searchLink fieldCode="DE" term="%22therapeutic+vaccination%22">therapeutic vaccination</searchLink><br /><searchLink fieldCode="DE" term="%22symptom+clusters%22">symptom clusters</searchLink><br /><searchLink fieldCode="DE" term="%22outcome%22">outcome</searchLink><br /><searchLink fieldCode="DE" term="%22Immunologic+diseases%2E+Allergy%22">Immunologic diseases. Allergy</searchLink><br /><searchLink fieldCode="DE" term="%22RC581-607%22">RC581-607</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: BackgroundWhile the short-term symptoms of post-COVID syndromes (PCS) are well-known, the long-term clinical characteristics, risk factors and outcomes of PCS remain unclear. Moreover, there is ongoing discussion about the effectiveness of post-infection vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) to aid in PCS recovery.MethodsIn this longitudinal and observational case-control study we aimed at identifying long-term PCS courses and evaluating the effects of post-infection vaccinations on PCS recovery. Individuals with initial mild COVID-19 were followed for a period of 15 months after primary infection. We assessed PCS outcomes, distinct symptom clusters (SC), and SARS-CoV-2 immunoglobulin G (IgG) levels in patients who received SARS-CoV-2 vaccination, as well as those who did not. To identify potential associating factors with PCS, we used binomial regression models and reported the results as odds ratios (OR) with 95% confidence intervals (95%CI).ResultsOut of 958 patients, follow-up data at 15 month after infection was obtained for 222 (23.2%) outpatients. Of those individuals, 36.5% (81/222) and 31.1% (69/222) were identified to have PCS at month 10 and 15, respectively. Fatigue and dyspnea (SC2) rather than anosmia and ageusia (SC1) constituted PCS at month 15. SARS-CoV-2 IgG levels were equally distributed over time among age groups, sex, and absence/presence of PCS. Of the 222 patients, 77.0% (171/222) were vaccinated between 10- and 15-months post-infection, but vaccination did not affect PCS recovery at month 15. 26.3% of unvaccinated and 25.8% of vaccinated outpatients improved from PCS (p= .9646). Baseline headache (SC4) and diarrhoea (SC5) were risk factors for PCS at months 10 and 15 (SC4: OR 1.85 (95%CI 1.04-3.26), p=.0390; SC5: OR 3.27(95%CI 1.54-6.64), p=.0009).ConclusionBased on the specific symptoms of PCS our findings show a shift in the pattern of recovery. We found no effect of SARS-CoV-2 vaccination on PCS recovery and recommend further studies to identify predicting biomarkers and targeted PCS therapeutics.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1664-3224
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1226622/full; https://doaj.org/toc/1664-3224
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3389/fimmu.2023.1226622
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/cd68ffa85084495d8def15fe468e058c" linkWindow="_blank">https://doaj.org/article/cd68ffa85084495d8def15fe468e058c</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.68ffa85084495d8def15fe468e058c
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.68ffa85084495d8def15fe468e058c
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1226622
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: post-COVID syndrome
        Type: general
      – SubjectFull: PCS
        Type: general
      – SubjectFull: long COVID
        Type: general
      – SubjectFull: therapeutic vaccination
        Type: general
      – SubjectFull: symptom clusters
        Type: general
      – SubjectFull: outcome
        Type: general
      – SubjectFull: Immunologic diseases. Allergy
        Type: general
      – SubjectFull: RC581-607
        Type: general
    Titles:
      – TitleFull: 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Max Augustin
      – PersonEntity:
          Name:
            NameFull: Melanie Stecher
      – PersonEntity:
          Name:
            NameFull: Hauke Wüstenberg
      – PersonEntity:
          Name:
            NameFull: Veronica Di Cristanziano
      – PersonEntity:
          Name:
            NameFull: Ute Sandaradura de Silva
      – PersonEntity:
          Name:
            NameFull: Lea Katharina Picard
      – PersonEntity:
          Name:
            NameFull: Elisabeth Pracht
      – PersonEntity:
          Name:
            NameFull: Dominic Rauschning
      – PersonEntity:
          Name:
            NameFull: Henning Gruell
      – PersonEntity:
          Name:
            NameFull: Florian Klein
      – PersonEntity:
          Name:
            NameFull: Christoph Wenisch
      – PersonEntity:
          Name:
            NameFull: Michael Hallek
      – PersonEntity:
          Name:
            NameFull: Philipp Schommers
      – PersonEntity:
          Name:
            NameFull: Clara Lehmann
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 16643224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in Immunology
              Type: main
ResultId 1